Trials / Completed
CompletedNCT00308347
A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes Mellitus and Nephropathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,513 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 31 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the effect of Losartan in reducing kidney disease in patients with Non-insulin Dependent Diabetes and Nephropathy (kidney damage that usually accompanies late stage Diabetes Mellitus).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954, losartan / Duration of Treatment: mean 3.4 years | |
| DRUG | Placebo / Duration of Treatment: mean 3.4 years |
Timeline
- Start date
- 1996-05-01
- Primary completion
- 2001-02-01
- Completion
- 2001-04-01
- First posted
- 2006-03-29
- Last updated
- 2022-02-15
Source: ClinicalTrials.gov record NCT00308347. Inclusion in this directory is not an endorsement.